Minretumomab: Difference between revisions
m (Protected "Minretumomab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
Line 26: | Line 26: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
Line 32: | Line 32: | ||
{{Mousemonoclonals}} | {{Mousemonoclonals}} | ||
[[Category:Monoclonal antibodies]] | [[Category:Monoclonal antibodies]] | ||
[[Category:Cancer treatments]] | [[Category:Cancer treatments]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Latest revision as of 17:27, 9 August 2012
WikiDoc Resources for Minretumomab |
Articles |
---|
Most recent articles on Minretumomab Most cited articles on Minretumomab |
Media |
Powerpoint slides on Minretumomab |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Minretumomab at Clinical Trials.gov Clinical Trials on Minretumomab at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Minretumomab
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Minretumomab Discussion groups on Minretumomab Patient Handouts on Minretumomab Directions to Hospitals Treating Minretumomab Risk calculators and risk factors for Minretumomab
|
Healthcare Provider Resources |
Causes & Risk Factors for Minretumomab |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Minretumomab is a mouse monoclonal antibody and which it is used to treat cancer.
Template:Mousemonoclonals Template:WH Template:WikiDoc Sources